ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)
Digital Twin in Healthcare Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
»óǰÄÚµå
:
1572930
¸®¼Ä¡»ç
:
Persistence Market Research
¹ßÇàÀÏ
:
2024³â 10¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 150 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
Persistence Market Research´Â ÃÖ±Ù ¼¼°è ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼´Â ½ÃÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µî Áß¿äÇÑ ½ÃÀå ¿ªÇÐÀ» öÀúÈ÷ Æò°¡ÇÏ°í ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ½ÉÃþÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ º¸°í¼´Â 2024³âºÎÅÍ 2031³â±îÁö ¼¼°è ÇコÄÉ¾î µðÁöÅÐ Æ®À© ½ÃÀåÀÇ ¿¹Ãø ¼ºÀå ±ËÀûÀ» °³°ýÇÏ´Â µ¶Á¡ µ¥ÀÌÅÍ¿Í Åë°è¸¦ ´ã°í ÀÖ½À´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
- ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå ±Ô¸ð(2024³â) : 25¾ï ´Þ·¯
- ¿¹»ó ½ÃÀå ±Ô¸ð(2031³â) : 746¾ï ´Þ·¯
- ¼¼°è ½ÃÀå ¼ºÀå·ü(2024-2031³â CAGR) : 66.7%
ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå - º¸°í¼ ¹üÀ§:
ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀåÀº »ç¹°ÀÎÅͳÝ(IoT), ÀΰøÁö´É(AI), ºòµ¥ÀÌÅÍ ºÐ¼®°ú °°Àº ÷´Ü ±â¼úÀ» Ȱ¿ëÇÏ¿© ȯÀÚ, Àå±â ¶Ç´Â ÇÁ·Î¼¼½ºÀÇ °¡»ó ¸ðµ¨À» »ý¼ºÇÕ´Ï´Ù. ÀÌ ±â¼úÀº ȯÀÚ Ä¡·á¿Í ¾÷¹« È¿À²¼ºÀ» Å©°Ô Çâ»ó½Ãų ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ¾î ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿ëµµ´Â °³ÀÎÈµÈ Ä¡·á °èȹ, Áø´Ü, À§Çè Æò°¡ µîÀ̸ç, ƯÈ÷ ½ÉÇ÷°ü Ä¡·á ºÐ¾ß¿¡¼ ¸¹ÀÌ È°¿ëµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ÃËÁø¿äÀÎ:
ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ¼¼°è ½ÃÀåÀº ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. µðÁöÅÐ Æ®À©Àº ´Ù¾çÇÑ µ¥ÀÌÅÍ ¼Ò½º¸¦ ÅëÇÕÇÏ¿© ȯÀÚÀÇ °¡»ó Ç¥ÇöÀ» ½±°Ô »ý¼ºÇÒ ¼ö Àֱ⠶§¹®¿¡ °³ÀÎÈµÈ ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ Áß¿äÇÑ ÃËÁø¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. À̸¦ ÅëÇØ ÀÇ·á ¼ºñ½º Á¦°øÀÚ´Â Ä¡·á¸¦ Á¶Á¤Çϰí, ¾à¹° ¿ä¹ýÀ» ÃÖÀûÈÇϰí, Áúº´ À§ÇèÀ» º¸´Ù È¿°úÀûÀ¸·Î ¿¹ÃøÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿þ¾î·¯ºí ±â±â ¹× »ç¹°ÀÎÅͳÝ(IoT)ÀÇ Çõ½ÅÀº ½Ç½Ã°£ µ¥ÀÌÅÍ ¼öÁý°ú ȯÀÚÀÇ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» °¡´ÉÇϰÔÇÔÀ¸·Î½á ÇコÄɾ º¯È¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖ°ÔÇÔÀ¸·Î½á Àüü ÀÇ·á ¼ºñ½º¸¦ °ÈÇϰí ȯÀÚ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ°Ô ÇÕ´Ï´Ù.
½ÃÀå ¾ïÁ¦¿äÀÎ:
ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀåÀº À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí, ±× ¹ßÀüÀ» ÀúÇØÇÏ´Â ¸î °¡Áö °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. µðÁöÅÐ Æ®À© ±â¼úÀ» µµÀÔÇϱâ À§Çؼ´Â IT ÀÎÇÁ¶ó, Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ, ±âÁ¸ ÇコÄÉ¾î ½Ã½ºÅÛ°úÀÇ ÅëÇÕ¿¡ ¸¹Àº ÀÚ±ÝÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ, ´Ù¾çÇÑ Ç÷§Æû °£ÀÇ ¿øÈ°ÇÑ µ¥ÀÌÅÍ ±³È¯À» º¹ÀâÇÏ°Ô ¸¸µå´Â »óÈ£¿î¿ë¼º ¹®Á¦µµ ÀÖ½À´Ï´Ù. °¢±â ´Ù¸¥ ½Ã½ºÅÛÀº Á¾Á¾ °íÀ¯ÇÑ Æ÷¸ËÀ» »ç¿ëÇϱ⠶§¹®¿¡ ½Ç½Ã°£ µ¥ÀÌÅÍ µ¿±âȸ¦ ¹æÇØÇÏ¿© °¡»ó ȯÀÚ ¸ðµ¨ÀÇ Á¤È®¼º°ú Àû½Ã¼º¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºÐ¾ß¿¡¼ µðÁöÅÐ Æ®À© ±â¼úÀÇ ÀáÀç·ÂÀ» ±Ø´ëÈÇϱâ À§Çؼ´Â ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇØ¾ß ÇÕ´Ï´Ù.
½ÃÀå ±âȸ:
ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀåÀº ±â¼ú ¹ßÀü°ú ÀÀ¿ë ºÐ¾ß È®´ë·Î ÀÎÇØ Å« ¼ºÀå ±âȸ¸¦ °¡Á®´Ù ÁÙ °ÍÀÔ´Ï´Ù. ÀÚµ¿È ¹× µðÁöÅÐ ±â¼úÀ» Á¦Á¶ °øÁ¤¿¡ ÅëÇÕÇÏ¸é »ý»ê¼º°ú ǰÁú °ü¸®°¡ °ÈµÇ¾î ½ÃÀå ÀáÀç·ÂÀ» ´õ¿í ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù.
º¸°í¼¿¡¼ ´äº¯ÇÑ ÁÖ¿ä Áú¹®
- ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
- ÇコÄÉ¾î ºÐ¾ß¿¡¼ µðÁöÅÐ Æ®À© ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â ¾ÖÇø®ÄÉÀ̼ǰú ±â¼úÀº ¹«¾ùÀΰ¡?
- ±â¼úÀÇ ¹ßÀüÀº ÇコÄÉ¾î µðÁöÅÐ Æ®À© ½ÃÀåÀÇ °æÀï ±¸µµ¸¦ ¾î¶»°Ô º¯È½Ã۰í Àִ°¡?
- ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ±â¾÷µéÀº ¾îµð¿¡ ÀÖÀ¸¸ç, ½ÃÀå °ü·Ã¼ºÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
- ¼¼°è ÇコÄÉ¾î µðÁöÅÐ Æ®À© ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå¿Í Àü¸ÁÀº?
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
- ½ÃÀå ¹üÀ§¿Í Á¤ÀÇ
- ½ÃÀå ¿ªÇÐ
- ¼ºÀå ÃËÁø¿äÀÎ
- ¼ºÀå ¾ïÁ¦¿äÀÎ
- ±âȸ
- ÁÖ¿ä µ¿Çâ
- °Å½Ã°æÁ¦ ¿äÀÎ
- ¼¼°èÀÇ ºÎ¹®º° Àü¸Á
- ¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
- ¼¼°èÀÇ ÇコÄɾî IT ÁöÃâ Àü¸Á
- COVID-19ÀÇ ¿µÇ⠺м®
- ¿¹Ãø¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
Á¦3Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®
- Á¦Ç° ä¿ë ºÐ¼®
- ±â¼ú Æò°¡
- ±ÔÁ¦ »óȲ
- °ø±Þ¸Á ºÐ¼®
- ÁÖ¿ä °Å·¡¿Í ÇÕº´
- PESTLE ºÐ¼®
- Porter's Five Forces ºÐ¼®
Á¦4Àå ¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)
- ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
- ½ÃÀå ±Ô¸ð¿Í Àü³âºñ ¼ºÀå·ü
- Àý´ëÀûÀÎ $ ±âȸ
- ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø
- °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®, 2019-2023³â
- ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø, 2024-2031³â
- ¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå Àü¸Á : ±¸¼º¿ä¼Òº°
- ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
- °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : ±¸¼º¿ä¼Òº°, 2019-2023³â ÇØ
- ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ±¸¼º¿ä¼Òº°, 2024-2031³â
- ½ÃÀå ¸Å·Â ºÐ¼® : ±¸¼º¿ä¼Òº°
- ¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå Àü¸Á : ¿ëµµº°
- ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
- °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : ¿ëµµº°, 2019-2023³â ÇØ
- ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°, 2024-2031³â
- ÆÐ½º³Î¶óÀÌÁî ÀÇ·á
- ¼ö¼ú °èȹ°ú ÀÇÇÐ ±³À°
- ÀǾàǰ ¹ß°ß°ú °³¹ß
- ÀÇ·á±â±â ¼³°è¿Í Å×½ºÆ®
- ÇコÄÉ¾î ¿öÅ©Ç÷οì ÃÖÀûÈ¿Í ÀÚ»ê °ü¸®
- ±âŸ
- ½ÃÀå ¸Å·Â ºÐ¼® : ¿ëµµº°
- ¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå Àü¸Á : ÃÖÁ¾»ç¿ëÀÚº°
- ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
- °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°, 2019-2023³â
- ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2024-2031³â
- ÀÇ·á±â±â ±â¾÷
- Á¦¾à¡¤¹ÙÀÌ¿ÀÀǾàǰ ±â¾÷
- ÇмúÁ¶»ç±â°ü
- ÇコÄɾî Á¦°øÀÚ
- ±âŸ
- ½ÃÀå ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
Á¦5Àå ¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå Àü¸Á : Áö¿ªº°
- ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
- °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Áö¿ªº°, 2019-2023³â
- ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°, 2024-2031³â
- ºÏ¹Ì
- À¯·´
- µ¿¾Æ½Ã¾Æ
- ³²¾Æ½Ã¾Æ¿Í ¿À¼¼¾Æ´Ï¾Æ
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ªº°
Á¦6Àå ºÏ¹ÌÀÇ ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)
Á¦7Àå À¯·´ÀÇ ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)
Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)
Á¦9Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)
Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)
Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)
Á¦12Àå °æÀï »óȲ
- ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
- ½ÃÀå ±¸Á¶
- ½ÃÀ庰 °æÀï °ÝÈ ¸Ê
- °æÀï ´ë½Ãº¸µå
- ±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±ÙÀÇ µ¿Çâ)
- Seimens Healthineers AG
- Dassault Systemes
- Microsoft
- Koninklijke Philips NV
- ANSYS, Inc.
- Predictiv
- Verto Health
- IBM
- Altair Engineering Inc
- NVIDIA Corporation
- GE Healthcare
- Oracle
- SAP
- Nutanix
- Reapmind Innovation Labs Pvt Ltd
- Faststream Technologies
- Simq GmbH
- Rescale, Inc.
- PrediSurge
- Unlearn AI
- ThoughtWire
- Amazon Web Services, Inc.
- dSPACE GmbH
- Innova Solutions
Á¦13Àå ºÎ·Ï
- Á¶»ç ¹æ¹ý
- Á¶»ç °¡Á¤
- µÎ¹®ÀÚ¾î¿Í ¾à¾î
ksm
¿µ¹® ¸ñÂ÷
Persistence Market Research has recently released a comprehensive report on the worldwide Digital Twin in Healthcare market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global Digital Twin in Healthcare market from 2024 to 2031.
Key Insights:
- Digital Twin in Healthcare Market Size (2024E): US$2.5 Billion
- Projected Market Value (2031F): US$74.6 Billion
- Global Market Growth Rate (CAGR 2024 to 2031): 66.7%
Digital Twin in Healthcare Market - Report Scope:
The Digital Twin in Healthcare market leverages advanced technologies such as Internet of Things (IoT), artificial intelligence (AI), and big data analytics to create virtual models of patients, organs, or processes. This technology has gained momentum due to its potential to significantly enhance patient care and operational efficiencies. Major applications include personalized treatment planning, diagnosis, and risk assessment, particularly in the cardiovascular care sector.
Market Growth Drivers:
The global Digital Twin in Healthcare market is propelled by several key factors. One significant driver is the growing demand for personalized medicine, as digital twins facilitate the creation of virtual representations of patients by integrating diverse data sources. This enables healthcare providers to tailor treatments, optimize drug therapies, and predict disease risks more effectively. Additionally, technological innovations in wearable devices and the Internet of Things (IoT) are transforming healthcare by enabling real-time data collection and continuous monitoring of patients. These advancements allow for timely interventions, enhancing overall healthcare delivery and improving patient outcomes.
Market Restraints:
Despite promising growth prospects, the Digital Twin in Healthcare market faces several challenges that could impede its progress. One significant hurdle is the high initial investment costs; implementing digital twin technologies necessitates substantial financial outlays for IT infrastructure, cloud computing, and integration with existing healthcare systems. Furthermore, interoperability challenges complicate the seamless exchange of data between various platforms. Different systems often utilize proprietary formats, which can hinder real-time data synchronization and affect the accuracy and timeliness of virtual patient models. Addressing these issues is essential for unlocking the full potential of digital twin technologies in the healthcare sector.
Market Opportunities:
The Digital Twin in Healthcare market presents significant growth opportunities driven by technological advancements and expanding applications. The integration of automation and digital technologies into manufacturing processes enhances productivity and quality control, further enhancing the market's potential.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the Digital Twin in Healthcare market globally?
- Which applications and technologies are fueling the adoption of digital twin solutions across the healthcare sector?
- How are advancements in technology reshaping the competitive landscape of the Digital Twin in Healthcare market?
- Who are the key players contributing to the Digital Twin in Healthcare market, and what strategies are they employing to maintain market relevance?
- What are the emerging trends and future prospects in the global Digital Twin in Healthcare market?
Competitive Intelligence and Business Strategy:
Leading players in the global Digital Twin in Healthcare market, including major healthcare technology firms, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest heavily in R&D to develop advanced digital twin technologies that cater to diverse healthcare needs, ensuring compliance with data privacy regulations and implementing robust security measures.
Key Companies Profiled:
- Seimens Healthineers AG
- Dassault Systemes
- Microsoft
- Koninklijke Philips N.V.
- ANSYS, Inc.
- Predictiv
- Verto Health
- IBM
- Altair Engineering Inc
- NVIDIA Corporation
- GE Healthcare
- Oracle
- SAP
- Nutanix
- Reapmind Innovation Labs Pvt Ltd
- Faststream Technologies
- Simq GmbH
- Rescale, Inc.
- PrediSurge
- Unlearn AI
- ThoughtWire
- Amazon Web Services, Inc.
- dSPACE GmbH
- Innova Solutions
Digital Twin in Healthcare Market Segmentation
By Component
By Application
- Personalised Medicine
- Surgical Planning & Medical Education
- Drug Discovery & Development
- Medical Device Design & Testing
- Healthcare Workflow Optimization & Asset Management
- Others
By End User
- Medical Device Companies
- Pharma & Biopharma Companies
- Academic & Research Institutes
- Healthcare Providers
- Others
By Region
- North America
- Europe
- East Asia
- South Asia and Oceania
- Latin America
- Middle East and Africa
Table of Contents
1. Executive Summary
- 1.1. Global Digital Twins in Healthcare Market Snapshot, 2024-2031
- 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
- 2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.3.3. Global Healthcare IT Spending Outlook
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
- 3.1. Product Adoption Analysis
- 3.2. Technology Assessment
- 3.3. Regulatory Landscape
- 3.4. Supply Chain Analysis
- 3.5. Key Deals and Mergers
- 3.6. PESTLE Analysis
- 3.7. Porter's Five Force Analysis
4. Global Digital Twins in Healthcare Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 4.1. Key Highlights
- 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
- 4.2. Market Size (US$ Mn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2023
- 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2024-2031
- 4.3. Global Digital Twins in Healthcare Market Outlook: Component
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Mn) Analysis, By Component, 2019-2023
- 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2031
- 4.3.3.1. Software
- 4.3.3.2. Services
- 4.4. Market Attractiveness Analysis: Component
- 4.5. Global Digital Twins in Healthcare Market Outlook: Application
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
- 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
- 4.5.3.1. Personalized Medicine
- 4.5.3.2. Surgical Planning & Medical Education
- 4.5.3.3. Drug Discovery & Development
- 4.5.3.4. Medical Device Design & Testing
- 4.5.3.5. Healthcare Workflow Optimization & Asset Management
- 4.5.3.6. Others
- 4.6. Market Attractiveness Analysis: Application
- 4.7. Global Digital Twins in Healthcare Market Outlook: End User
- 4.7.1. Introduction / Key Findings
- 4.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
- 4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
- 4.7.3.1. Medical Device Companies
- 4.7.3.2. Pharma & Biopharma Companies
- 4.7.3.3. Academic & Research Institutes
- 4.7.3.4. Healthcare Providers
- 4.7.3.5. Others
- 4.8. Market Attractiveness Analysis: End User
5. Global Digital Twins in Healthcare Market Outlook: Region
- 5.1. Key Highlights
- 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
- 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
- 5.4. Market Attractiveness Analysis: Region
6. North America Digital Twins in Healthcare Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
- 6.2.1. By Country
- 6.2.2. By Component
- 6.2.3. By Application
- 6.2.4. By End User
- 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
- 6.3.1. U.S.
- 6.3.2. Canada
- 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2031
- 6.4.1. Software
- 6.4.2. Services
- 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
- 6.5.1. Personalized Medicine
- 6.5.2. Surgical Planning & Medical Education
- 6.5.3. Drug Discovery & Development
- 6.5.4. Medical Device Design & Testing
- 6.5.5. Healthcare Workflow Optimization & Asset Management
- 6.5.6. Others
- 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
- 6.6.1. Medical Device Companies
- 6.6.2. Pharma & Biopharma Companies
- 6.6.3. Academic & Research Institutes
- 6.6.4. Healthcare Providers
- 6.6.5. Others
- 6.7. Market Attractiveness Analysis
7. Europe Digital Twins in Healthcare Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
- 7.2.1. By Country
- 7.2.2. By Component
- 7.2.3. By Application
- 7.2.4. By End User
- 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkiye
- 7.3.8. Rest of Europe
- 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2031
- 7.4.1. Software
- 7.4.2. Services
- 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
- 7.5.1. Personalized Medicine
- 7.5.2. Surgical Planning & Medical Education
- 7.5.3. Drug Discovery & Development
- 7.5.4. Medical Device Design & Testing
- 7.5.5. Healthcare Workflow Optimization & Asset Management
- 7.5.6. Others
- 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
- 7.6.1. Medical Device Companies
- 7.6.2. Pharma & Biopharma Companies
- 7.6.3. Academic & Research Institutes
- 7.6.4. Healthcare Providers
- 7.6.5. Others
- 7.7. Market Attractiveness Analysis
8. East Asia Digital Twins in Healthcare Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
- 8.2.1. By Country
- 8.2.2. By Component
- 8.2.3. By Application
- 8.2.4. By End User
- 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2031
- 8.4.1. Software
- 8.4.2. Services
- 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
- 8.5.1. Personalized Medicine
- 8.5.2. Surgical Planning & Medical Education
- 8.5.3. Drug Discovery & Development
- 8.5.4. Medical Device Design & Testing
- 8.5.5. Healthcare Workflow Optimization & Asset Management
- 8.5.6. Others
- 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
- 8.6.1. Medical Device Companies
- 8.6.2. Pharma & Biopharma Companies
- 8.6.3. Academic & Research Institutes
- 8.6.4. Healthcare Providers
- 8.6.5. Others
- 8.7. Market Attractiveness Analysis
9. South Asia & Oceania Digital Twins in Healthcare Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
- 9.2.1. By Country
- 9.2.2. By Component
- 9.2.3. By Application
- 9.2.4. By End User
- 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
- 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2031
- 9.4.1. Software
- 9.4.2. Services
- 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
- 9.5.1. Personalized Medicine
- 9.5.2. Surgical Planning & Medical Education
- 9.5.3. Drug Discovery & Development
- 9.5.4. Medical Device Design & Testing
- 9.5.5. Healthcare Workflow Optimization & Asset Management
- 9.5.6. Others
- 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
- 9.6.1. Medical Device Companies
- 9.6.2. Pharma & Biopharma Companies
- 9.6.3. Academic & Research Institutes
- 9.6.4. Healthcare Providers
- 9.6.5. Others
- 9.7. Market Attractiveness Analysis
10. Latin America Digital Twins in Healthcare Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
- 10.2.1. By Country
- 10.2.2. By Component
- 10.2.3. By Application
- 10.2.4. By End User
- 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
- 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2031
- 10.4.1. Software
- 10.4.2. Services
- 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
- 10.5.1. Personalized Medicine
- 10.5.2. Surgical Planning & Medical Education
- 10.5.3. Drug Discovery & Development
- 10.5.4. Medical Device Design & Testing
- 10.5.5. Healthcare Workflow Optimization & Asset Management
- 10.5.6. Others
- 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
- 10.6.1. Medical Device Companies
- 10.6.2. Pharma & Biopharma Companies
- 10.6.3. Academic & Research Institutes
- 10.6.4. Healthcare Providers
- 10.6.5. Others
- 10.7. Market Attractiveness Analysis
11. Middle East & Africa Digital Twins in Healthcare Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
- 11.2.1. By Country
- 11.2.2. By Component
- 11.2.3. By Application
- 11.2.4. By End User
- 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
- 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2031
- 11.4.1. Software
- 11.4.2. Services
- 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
- 11.5.1. Personalized Medicine
- 11.5.2. Surgical Planning & Medical Education
- 11.5.3. Drug Discovery & Development
- 11.5.4. Medical Device Design & Testing
- 11.5.5. Healthcare Workflow Optimization & Asset Management
- 11.5.6. Others
- 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
- 11.6.1. Medical Device Companies
- 11.6.2. Pharma & Biopharma Companies
- 11.6.3. Academic & Research Institutes
- 11.6.4. Healthcare Providers
- 11.6.5. Others
- 11.7. Market Attractiveness Analysis
12. Competition Landscape
- 12.1. Market Share Analysis, 2024
- 12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
- 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Seimens Healthineers AG
- 12.3.1.1. Overview
- 12.3.1.2. Segments and Products
- 12.3.1.3. Key Financials
- 12.3.1.4. Market Developments
- 12.3.1.5. Market Strategy
- 12.3.2. Dassault Systemes
- 12.3.2.1. Overview
- 12.3.2.2. Segments and Products
- 12.3.2.3. Key Financials
- 12.3.2.4. Market Developments
- 12.3.2.5. Market Strategy
- 12.3.3. Microsoft
- 12.3.3.1. Overview
- 12.3.3.2. Segments and Products
- 12.3.3.3. Key Financials
- 12.3.3.4. Market Developments
- 12.3.3.5. Market Strategy
- 12.3.4. Koninklijke Philips N.V.
- 12.3.4.1. Overview
- 12.3.4.2. Segments and Products
- 12.3.4.3. Key Financials
- 12.3.4.4. Market Developments
- 12.3.4.5. Market Strategy
- 12.3.5. ANSYS, Inc.
- 12.3.5.1. Overview
- 12.3.5.2. Segments and Products
- 12.3.5.3. Key Financials
- 12.3.5.4. Market Developments
- 12.3.5.5. Market Strategy
- 12.3.6. Predictiv
- 12.3.6.1. Overview
- 12.3.6.2. Segments and Products
- 12.3.6.3. Key Financials
- 12.3.6.4. Market Developments
- 12.3.6.5. Market Strategy
- 12.3.7. Verto Health
- 12.3.7.1. Overview
- 12.3.7.2. Segments and Products
- 12.3.7.3. Key Financials
- 12.3.7.4. Market Developments
- 12.3.7.5. Market Strategy
- 12.3.8. IBM
- 12.3.8.1. Overview
- 12.3.8.2. Segments and Products
- 12.3.8.3. Key Financials
- 12.3.8.4. Market Developments
- 12.3.8.5. Market Strategy
- 12.3.9. Altair Engineering Inc
- 12.3.9.1. Overview
- 12.3.9.2. Segments and Products
- 12.3.9.3. Key Financials
- 12.3.9.4. Market Developments
- 12.3.9.5. Market Strategy
- 12.3.10. NVIDIA Corporation
- 12.3.10.1. Overview
- 12.3.10.2. Segments and Products
- 12.3.10.3. Key Financials
- 12.3.10.4. Market Developments
- 12.3.10.5. Market Strategy
- 12.3.11. GE Healthcare
- 12.3.11.1. Overview
- 12.3.11.2. Segments and Products
- 12.3.11.3. Key Financials
- 12.3.11.4. Market Developments
- 12.3.11.5. Market Strategy
- 12.3.12. Oracle
- 12.3.12.1. Overview
- 12.3.12.2. Segments and Products
- 12.3.12.3. Key Financials
- 12.3.12.4. Market Developments
- 12.3.12.5. Market Strategy
- 12.3.13. SAP
- 12.3.13.1. Overview
- 12.3.13.2. Segments and Products
- 12.3.13.3. Key Financials
- 12.3.13.4. Market Developments
- 12.3.13.5. Market Strategy
- 12.3.14. Nutanix
- 12.3.14.1. Overview
- 12.3.14.2. Segments and Products
- 12.3.14.3. Key Financials
- 12.3.14.4. Market Developments
- 12.3.14.5. Market Strategy
- 12.3.15. Reapmind Innovation Labs Pvt Ltd
- 12.3.15.1. Overview
- 12.3.15.2. Segments and Products
- 12.3.15.3. Key Financials
- 12.3.15.4. Market Developments
- 12.3.15.5. Market Strategy
- 12.3.16. Faststream Technologies
- 12.3.16.1. Overview
- 12.3.16.2. Segments and Products
- 12.3.16.3. Key Financials
- 12.3.16.4. Market Developments
- 12.3.16.5. Market Strategy
- 12.3.17. Simq GmbH
- 12.3.17.1. Overview
- 12.3.17.2. Segments and Products
- 12.3.17.3. Key Financials
- 12.3.17.4. Market Developments
- 12.3.17.5. Market Strategy
- 12.3.18. Rescale, Inc.
- 12.3.18.1. Overview
- 12.3.18.2. Segments and Products
- 12.3.18.3. Key Financials
- 12.3.18.4. Market Developments
- 12.3.18.5. Market Strategy
- 12.3.19. PrediSurge
- 12.3.19.1. Overview
- 12.3.19.2. Segments and Products
- 12.3.19.3. Key Financials
- 12.3.19.4. Market Developments
- 12.3.19.5. Market Strategy
- 12.3.20. Unlearn AI
- 12.3.20.1. Overview
- 12.3.20.2. Segments and Products
- 12.3.20.3. Key Financials
- 12.3.20.4. Market Developments
- 12.3.20.5. Market Strategy
- 12.3.21. ThoughtWire
- 12.3.21.1. Overview
- 12.3.21.2. Segments and Products
- 12.3.21.3. Key Financials
- 12.3.21.4. Market Developments
- 12.3.21.5. Market Strategy
- 12.3.22. Amazon Web Services, Inc.
- 12.3.22.1. Overview
- 12.3.22.2. Segments and Products
- 12.3.22.3. Key Financials
- 12.3.22.4. Market Developments
- 12.3.22.5. Market Strategy
- 12.3.23. dSPACE GmbH
- 12.3.23.1. Overview
- 12.3.23.2. Segments and Products
- 12.3.23.3. Key Financials
- 12.3.23.4. Market Developments
- 12.3.23.5. Market Strategy
- 12.3.24. Innova Solutions
- 12.3.24.1. Overview
- 12.3.24.2. Segments and Products
- 12.3.24.3. Key Financials
- 12.3.24.4. Market Developments
- 12.3.24.5. Market Strategy
13. Appendix
- 13.1. Research Methodology
- 13.2. Research Assumptions
- 13.3. Acronyms and Abbreviations
°ü·ÃÀÚ·á